GuruTrack
MRK

MRK

MERCK & CO. INC.

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary
MERCK & CO. INC. (MRK) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$1.33B; the largest are Jeremy Grantham, Ken Griffin, Izzy Englander. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 4 trimmed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders74 also report options
Congress trades20
Price$148.69vs quarter-end+15.71%
Sectors2
This quarter's moves
New1
Added1
Trimmed / sold4
Top holderJeremy Grantham

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Value $17.44M0.0% of portfolio135,7502026 Q2

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Value $482.76M— of portfolio3,756,9002026 Q2
Value $447.91M— of portfolio3,485,7002026 Q2
Value $156.87M— of portfolio1,220,8002026 Q2
Value $42.70M— of portfolio332,3002026 Q2
Value $39.42M— of portfolio306,8002026 Q2
Value $13.16M— of portfolio102,4002026 Q2
Value $9.02M— of portfolio70,2002026 Q2
Value $7.90M— of portfolio61,5002026 Q2

Insider Trading

Officers · directors · Form 4
Open-market purchases and sales (P/S)17
  • Chirfi Guindo

    EVP, Access, Policy & Comms

    Sell$1.35M
    10,000 @ $135.00Traded 2026-08-13Filed 2026-08-13
  • Jennifer Zachary

    EVP, General Counsel

    Sell$10.72M
    80,315 @ $133.46Traded 2026-08-12Filed 2026-08-13
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$973.2K
    7,410 @ $131.33Traded 2026-08-10Filed 2026-08-12
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$718.3K
    5,427 @ $132.35Traded 2026-08-10Filed 2026-08-12
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$79.2K
    600 @ $132.04Traded 2026-08-10Filed 2026-08-12
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$2.71M
    20,784 @ $130.43Traded 2026-08-10Filed 2026-08-12
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$1.46M
    11,099 @ $131.61Traded 2026-08-10Filed 2026-08-12
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$39.3K
    300 @ $131.02Traded 2026-08-06Filed 2026-08-10
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$105.5K
    805 @ $131.02Traded 2026-08-06Filed 2026-08-10
  • Richard R. Deluca

    EVP&Pres, Merck Animal Heallth

    Sell$644.0K
    4,945 @ $130.23Traded 2026-08-06Filed 2026-08-10
  • Chirfi Guindo

    EVP, Access, Policy & Comms

    Sell$1.97M
    15,000 @ $131.00Traded 2026-08-06Filed 2026-08-07
  • David Michael Williams

    EVP,Chief Info&Digital Officer

    Sell$592.3K
    4,600 @ $128.77Traded 2026-08-05Filed 2026-08-07
  • David Michael Williams

    EVP,Chief Info&Digital Officer

    Sell$1.74M
    13,542 @ $128.77Traded 2026-08-05Filed 2026-08-07
  • David R. Maraldo

    EVP & Pres. MMD

    Sell$345.7K
    2,686 @ $128.72Traded 2026-08-05Filed 2026-08-07
  • David R. Maraldo

    EVP & Pres. MMD

    Sell$812.3K
    6,311 @ $128.72Traded 2026-08-05Filed 2026-08-07
  • David R. Maraldo

    EVP & Pres. MMD

    Sell$1.25M
    9,709 @ $128.72Traded 2026-08-05Filed 2026-08-07
  • David Michael Williams

    EVP,Chief Info&Digital Officer

    Sell$4.47M
    34,705 @ $128.77Traded 2026-08-05Filed 2026-08-07

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.